Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China
NCT01933646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2015-01-07
Summary
Evaluate the burden of invasive group B streptococcal (GBS) disease in young infants (up to 90 days of age) in China, in terms of incidence, case fatality rate and serotype distribution
Conditions
- Invasive Group B Streptococcal Disease
Sponsors & Collaborators
-
Novartis Vaccines
lead INDUSTRY
Principal Investigators
-
Novartis Vaccines · Novartis Vaccines
Eligibility
- Max Age
- 90 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- China
Study Locations
More Related Trials
-
Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
NCT00734565 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine
NCT01086423 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
NCT02569879 ·Status: COMPLETED
-
Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age
NCT00379977 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine
NCT01449812 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.
NCT00609492 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
NCT00008853 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China
NCT01025544 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NCT06605755 ·Status: RECRUITING ·Phase: NA
-
Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine
NCT00158795 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
NCT02853929 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan
NCT01479491 ·Status: COMPLETED
-
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
NCT07286370 ·Status: RECRUITING ·Phase: PHASE2
-
Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children
NCT01125527 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine
NCT01021293 ·Status: COMPLETED ·Phase: PHASE3
-
Boostrix® Pregnancy Registry
NCT02096276 ·Status: COMPLETED
-
Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)
NCT00964028 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
NCT01098474 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
NCT00322335 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.
NCT00345683 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States
NCT03973905 ·Status: COMPLETED
-
Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine
NCT00289796 ·Status: COMPLETED ·Phase: PHASE2
-
3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age
NCT00129116 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea
NCT01929291 ·Status: COMPLETED
-
A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine
NCT02692859 ·Status: COMPLETED ·Phase: PHASE3